Correlation Between Newpark Resources and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Newpark Resources and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Newpark Resources and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Newpark Resources and Spyre Therapeutics, you can compare the effects of market volatilities on Newpark Resources and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Newpark Resources with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Newpark Resources and Spyre Therapeutics.

Diversification Opportunities for Newpark Resources and Spyre Therapeutics

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Newpark and Spyre is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Newpark Resources and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Newpark Resources is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Newpark Resources are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Newpark Resources i.e., Newpark Resources and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Newpark Resources and Spyre Therapeutics

Allowing for the 90-day total investment horizon Newpark Resources is expected to generate 0.55 times more return on investment than Spyre Therapeutics. However, Newpark Resources is 1.83 times less risky than Spyre Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.43 per unit of risk. If you would invest  725.00  in Newpark Resources on September 12, 2024 and sell it today you would earn a total of  57.00  from holding Newpark Resources or generate 7.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Newpark Resources  vs.  Spyre Therapeutics

 Performance 
       Timeline  
Newpark Resources 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Newpark Resources are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Newpark Resources may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Newpark Resources and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Newpark Resources and Spyre Therapeutics

The main advantage of trading using opposite Newpark Resources and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Newpark Resources position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind Newpark Resources and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data